Preston Klassen - 12 Jun 2023 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RGLS	Stock Option (Right to Buy)	Award	$0	+350,000		$0.000000	350,000	12 Jun 2023	Common Stock	350,000	$1.46	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	25% of the shares vest one year following the date of grant and the remainder of the shares vest in 36 equal installments on a monthly basis thereafter, such that the option is fully vested three years following the date of grant, subject to the reporting person's continuous service.